In this episode of the Tech Intersect Podcast, I speak with Chrissa McFarlane, named as one of the top women, “leaving their mark on the MedTech field in health IT,” by Becker’s Hospital Review. Chrissa is the Founder and CEO of Patientory, Inc., headquartered in Atlanta. She founded Patientory in December 2015 after seeing the need in the market for more personalized and secure consumer-driven health information management solutions. She leverages blockchain’s distributed ledger technology to solve for one of this century’s most pressing concerns, patient-control of their medical data. This episode is being released on April 8th, 2020 during the COVID-19 pandemic but our conversation took place a couple of months before.
LISTEN NOW
Guest social assets:
- Slack: https://patientory.com/slack
- Twitter: https://twitter.com/patientory
- Bitcoin Talk: https://bitcointalk.org/index.php?topic=1886446.0
- YouTube: https://www.youtube.com/channel/UCsTwOEvWGmSAhQ5OPG9kRQg
- LinkedIN: https://www.linkedin.com/company/patientory/
Links:
- https://patientory.com/
- Black women are earning more college degrees, but that alone won’t close race gaps (Brookings)
- Patientory App Demo: https://www.youtube.com/watch?v=Gq-OBdTKbrQ#action=share
- Patientory Case Study: https://patientory.com/wp-content/uploads/2019/11/Case_Study.pdf
- What is blockchain, by Tonya Evans: https://youtu.be/BWgAp2hpGRM
Contact:
- Questions and requests: hello@techintersectpodcast.com
- Follow: Twitter @AtTechIntersect Instagram @TechIntersect
- Web: http://www.TechIntersectPodcast.com
- Mailing List: http://eepurl.com/gKqDyP
UPGRADE YOUR EXPERIENCE
Want early access to episodes, exclusive content including full show notes, live video chats and replays, a copy of e-books, webinars and access to courses in the Advantage Evans Academy?
Subscribe to Advantage Evans™ Plus, Advantage Evans Premium™ or Advantage Evans Pro™
Early Access Subscriber Content (available only to Advantage Evans™ members)
[mepr-show if=”rule: 609″]
Excuse content Advantage Evans delays due to COVID19‘s impact
[/mepr-show]